Issue 62, 2014

SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis

Abstract

We report a highly sensitive detection method for anti-CCP autoantibodies using a SERS-based magnetic immunosensor. The proposed immunoassay technique is expected to be a new clinical tool for the early diagnosis of rheumatoid arthritis (RA).

Graphical abstract: SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis

Supplementary files

Article information

Article type
Communication
Submitted
30 May 2014
Accepted
16 Jul 2014
First published
16 Jul 2014

RSC Adv., 2014,4, 32924-32927

Author version available

SERS-based immunoassay of anti-cyclic citrullinated peptide for early diagnosis of rheumatoid arthritis

H. Chon, S. Lee, R. Wang, S. Bang, H. Lee, S. Bae, H. Lee, B. Kim and J. Choo, RSC Adv., 2014, 4, 32924 DOI: 10.1039/C4RA05149A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements